- Tytuł:
- Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).
- Autorzy:
- Źródło:
- Trials [Trials] 2024 Mar 22; Vol. 25 (1), pp. 213. Date of Electronic Publication: 2024 Mar 22.
- Typ publikacji:
- Clinical Trial Protocol; Journal Article
- MeSH Terms:
-
Antibodies, Monoclonal, Humanized*/therapeutic use
Kidney Transplantation */adverse effects
Humans ; Graft Rejection ;Kidney ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe